These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3278433)
1. Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy. Cantarovich F; Bizollon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J Transplantation; 1988 Feb; 45(2):389-94. PubMed ID: 3278433 [TBL] [Abstract][Full Text] [Related]
2. [Plasma levels of cyclosporin 6 hours after its oral administration, T6: key to the surveillance of the treatment]. Cantarovich F; Bizzolon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J Nephrologie; 1987; 8(3):111-22. PubMed ID: 3658087 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection. Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851 [TBL] [Abstract][Full Text] [Related]
4. Is serum creatinine a reliable expression of an adequate cyclosporine immunosuppression? Cantarovich F; Cantarovich D; Suso E; Lefrançois N; Touraine JL; Traeger J Clin Nephrol; 1988 Jan; 29(1):9-11. PubMed ID: 3289807 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation. Lindholm A; Dahlqvist R; Groth GG; Sjöqvist F Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients. Cantarovich M; Besner JG; Fitchett DH; Latter DA Clin Transplant; 1997 Oct; 11(5 Pt 1):399-405. PubMed ID: 9361930 [TBL] [Abstract][Full Text] [Related]
8. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients? Ubhi CS; Woodhouse L; Guillou PJ; Giles GR Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426 [TBL] [Abstract][Full Text] [Related]
9. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood. Arnold AN; Waltzer WC; Anaise D; Weinstein SW; Rapaport FT Transplantation; 1985 Dec; 40(6):605-10. PubMed ID: 3907030 [TBL] [Abstract][Full Text] [Related]
10. RIA plasma cyclosporine values six hours after oral administration (T6)--an easy solution to a difficult therapeutic problem: a retrospective and prospective study. Cantarovich F; Bizollon C; Cantarovich D; Lefrancois N; Dubernard JM; Mizony Busnardo ME; De Arteaga J; Suso E; Mpio I; Traeger J Transplant Proc; 1987 Feb; 19(1 Pt 2):1723-5. PubMed ID: 3274415 [No Abstract] [Full Text] [Related]
11. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation]. Zhu L; Ding T; Wang XX; Lin ZB; Chen G Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681 [TBL] [Abstract][Full Text] [Related]
12. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Canadian Neoral Renal Transplantation Study Group Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295 [TBL] [Abstract][Full Text] [Related]
13. The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients. Kasiske BL; Heim-Duthoy K; Rao KV; Awni WM Transplantation; 1988 Nov; 46(5):716-22. PubMed ID: 3057694 [TBL] [Abstract][Full Text] [Related]
15. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation. Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine. Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine dose adjustment using levels obtained six hours after the morning dose: effect on side effects in patients with autoimmune diseases. Cantarovich M; Deschênes J Am J Nephrol; 1997; 17(5):450-7. PubMed ID: 9382165 [TBL] [Abstract][Full Text] [Related]
18. Improved immunosuppression for heart transplant patients using intravenous doses of cyclosporine. Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Kahan BD Transplantation; 1989 Feb; 47(2):311-4. PubMed ID: 2493177 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation. Brennan DC; Stratta RJ; Lowell JA; Miller SA; Taylor RJ Transplantation; 1994 Jun; 57(11):1606-11. PubMed ID: 8009595 [TBL] [Abstract][Full Text] [Related]
20. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation. Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]